Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Right Now

Plasma Derived Therapy
Market Research Report Analysis and Forecasts to 2030

Rising adoption of immunoglobulin across nation is expected to boost the market forecasts. Plasma-derived immunoglobulin is widely used for a range of inflammatory and autoimmune diseases. Surge in recognition and treatment of immune deficiencies has increased demand for immunoglobulins. Moreover, the number of clinical indications for plasma derived products has been growing in recent years. Immunoglobulin has become a key treatment option in several clinical indications including acute inflammatory and autoimmune conditions. Demand for such therapies is rising because of off-label use in various applications, particularly for the treatment of immunological deficiencies and neurological disorders.

The rising development of new plasma collection centers by the major plasma derived therapy industry players is anticipated to drive the market demand. For instance, in March 2022, ADMA Biologics announced U.S. FDA approval for its 5th ADMA BioCenters plasma collection facility at Georgia. Therefore, successful expansion of such plasma collection centers will spur the industry statistics. Furthermore, increasing awareness regarding blood donation and blood related disorders is further projected to accelerate industry progression.

To access a sample copy or view the market report in detail along with the table of

contents, please click the link below: https://www.gminsights.com/request-sample/detail/5271

Increasing prevalence of hemophilia among population will influence the industry expansion

Coagulation factors segment was accounted for 15% market share in 2021 and is set to register a significant CAGR through 2030. This is attributable to growing prevalence of hemophilia disorders coupled with significant investment towards development of effective treatment. According to the Centers for Disease Control and Prevention (CDC) in the U.S. hemophilia affects approximately 1 in 5,617 male births. Therefore, increasing number of patients suffering from hemophilia will propel the market trends.

Browse key industry insights spread across 108 pages with 123 market data tables & 11 figures & charts from the report, “Plasma Derived Therapy Market Analysis By Product (Coagulation Factors, Immunoglobulins, Albumin), Application (Primary Immunodeficiency Diseases, Hemophilia, Idiopathic Thrombocytopenic Purpura (ITP)), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/plasma-derived-therapy-market

Increasing preference for plasma derived therapies for treatment of rare diseases will augment the market outlook

Plasma derived therapy market from primary immunodeficiency diseases segment held over USD 4.2 billion in 2021. This is owing to increasing awareness regarding plasma derived therapy for the treatment of primary immunodeficiency disease. It is a genetic disorder in the immune system that represents a missing part or abnormal function Moreover, increasing research and development activities for the development of advanced plasma derived therapy will further contribute to the segment revenue.

Growing elderly population susceptible to suffer from rare diseases in Europe will augment the industry scenario

Europe plasma derived therapy market is estimated to progress at 7.2% CAGR during the analysis period. The is due to the rising geriatric population base that is more susceptible to several immunological and neurological disorders and is said to gradually increase the demand for plasma derived therapy. Additionally, the companies operating in the region are increasingly focusing on the introduction of innovative therapy for diseases management. Thus, increasing investment in plasma fractionation coupled with availability of well-equipped facilities will stimulate the regional business landscape.

Strategic collaborations by the leading industry players will strengthen their business reach

Some of the major players operating in the plasma derived therapy industry are CSL Behring, Takeda Pharmaceutical Company Limited, Biotest AG, Octapharma, BPL, ADMA Biologics, Grifols, SA, Kedrion, Kamada Pharmaceuticals, SK Plasma, Pfizer. These companies are undertaking several business growth strategies such as acquisitions and collaborations to expand their business presence.

For instance, in July 2021, Octapharma AG received FDA approval for its Octagram 10%, intravenous immunoglobulin (IVIg). The product is used for treatment of rare immune-mediated inflammatory disease “adult dermatomyositis”. Therefore, such products approvals will help company to strengthen its product portfolio and generate more revenues.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle east & Africa

Chapter 2   Executive Summary

2.1    Plasma derived therapy industry 360° synopsis, 2017 – 2030

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    Regional trends

Browse complete table of content of this report@ https://www.gminsights.com/industry-analysis/plasma-derived-therapy-market

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Aashit Tiwari

Corporate Sales, USA

Global Market Insights Inc.

Toll Free: +1-888-689-0688

USA: +1-302-846-7766

Europe: +44-742-759-8484

APAC: +65-3129-7718

Email: sales@gminsights.com

More Posts

0 comments
U Ss
20 Oct 2022
0 comments
U Sm
17 Oct 2022
0 comments
0 comments
U Sm
10 Oct 2022
0 comments
0 comments
Load More wait